173 related articles for article (PubMed ID: 27635065)
1. The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.
Zhu CS; Huang WY; Pinsky PF; Berg CD; Sherman M; Yu KJ; Carrick DM; Black A; Hoover R; Lenz P; Williams C; Hawkins L; Chaloux M; Yurgalevitch S; Mathew S; Miller A; Olivo V; Khan A; Pretzel SM; Multerer D; Beckmann P; Broski KG; Freedman ND
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1635-1642. PubMed ID: 27635065
[TBL] [Abstract][Full Text] [Related]
2. The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource.
Carrick DM; Black A; Gohagan JK; Khan A; Pettit K; Williams C; Yu K; Yurgalevitch S; Huang WY; Zhu C
Rev Recent Clin Trials; 2015; 10(3):212-22. PubMed ID: 26238117
[TBL] [Abstract][Full Text] [Related]
3. The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.
Zhu CS; Pinsky PF; Kramer BS; Prorok PC; Purdue MP; Berg CD; Gohagan JK
J Natl Cancer Inst; 2013 Nov; 105(22):1684-93. PubMed ID: 24115361
[TBL] [Abstract][Full Text] [Related]
4. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
[TBL] [Abstract][Full Text] [Related]
5. Data Processing and Analytic Support in the PLCO Cancer Screening Trial.
Mabie J; Riley T; Marcus PM; Black A; Rozjabek H; Yu K; Young M; Austin J; Rathmell J; Williams C; Prorok PC
Rev Recent Clin Trials; 2015; 10(3):233-7. PubMed ID: 26238116
[TBL] [Abstract][Full Text] [Related]
6. PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies.
Black A; Huang WY; Wright P; Riley T; Mabie J; Mathew S; Ragard L; Hermansen S; Yu K; Pinsky P; Prorok PC; Freedman ND; Hoover RN
Rev Recent Clin Trials; 2015; 10(3):238-45. PubMed ID: 26435289
[TBL] [Abstract][Full Text] [Related]
7. Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial.
Prorok PC; Wright P; Riley TR; Kramer BS; Berg CD; Gohagan JK
Rev Recent Clin Trials; 2018; 13(4):257-273. PubMed ID: 29629665
[TBL] [Abstract][Full Text] [Related]
8. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Doria-Rose VP; Laiyemo AO; Church T; Yokochi LA; Yurgalevitch S; Rathmell J; Andriole GL; Buys S; Crawford ED; Fouad M; Isaacs C; Lamerato L; Reding D; Prorok PC; Berg CD;
J Natl Cancer Inst; 2012 Feb; 104(4):280-9. PubMed ID: 22298838
[TBL] [Abstract][Full Text] [Related]
9. Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial.
Grubb RL; Pinsky P; Prorok PC; Andriole GL
Eur Urol; 2015 Oct; 68(4):545-6. PubMed ID: 25959167
[TBL] [Abstract][Full Text] [Related]
10. Focused Decision Support: a Data Mining Tool to Query the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset and Guide Screening Management for the Individual Patient.
Sharma A; Hostetter J; Morrison J; Wang K; Siegel E
J Digit Imaging; 2016 Apr; 29(2):160-4. PubMed ID: 26385814
[TBL] [Abstract][Full Text] [Related]
11. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
Gohagan JK; Prorok PC; Hayes RB; Kramer BS;
Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683
[TBL] [Abstract][Full Text] [Related]
12. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.
Hayes RB; Reding D; Kopp W; Subar AF; Bhat N; Rothman N; Caporaso N; Ziegler RG; Johnson CC; Weissfeld JL; Hoover RN; Hartge P; Palace C; Gohagan JK;
Control Clin Trials; 2000 Dec; 21(6 Suppl):349S-355S. PubMed ID: 11189687
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Quality Management (CQM) in the PLCO Trial.
Gohagan JK; O'Brien B; Hasson MA; Umbel KD; Bridgeman B; Kramer BS; Reding D; Gren L; Wright P; Riley T; Prorok PC
Rev Recent Clin Trials; 2015; 10(3):223-32. PubMed ID: 26238118
[TBL] [Abstract][Full Text] [Related]
14. Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.
O'Grady TJ; Kitahara CM; DiRienzo AG; Boscoe FP; Gates MA
PLoS One; 2014; 9(9):e106880. PubMed ID: 25192282
[TBL] [Abstract][Full Text] [Related]
15. The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.
Gohagan JK; Prorok PC; Greenwald P; Kramer BS
Rev Recent Clin Trials; 2015; 10(3):173-80. PubMed ID: 26238115
[TBL] [Abstract][Full Text] [Related]
16. Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial.
Bazzi L; Lamerato LE; Varner J; Shambaugh VL; Cordes JE; Ragard LR; Marcus PM
Rev Recent Clin Trials; 2015; 10(3):200-5. PubMed ID: 26238207
[TBL] [Abstract][Full Text] [Related]
17. Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Miller AB; Feld R; Fontana R; Gohagan JK; Jatoi I; Lawrence W; Miller A; ProroK PC; Rajput A; Sherman M; Welch G; Wright P; Yurgalevitch S; Albertsen P
Rev Recent Clin Trials; 2015; 10(3):206-11. PubMed ID: 26238119
[TBL] [Abstract][Full Text] [Related]
18. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Stallings FL; Ford ME; Simpson NK; Fouad M; Jernigan JC; Trauth JM; Miller DS;
Control Clin Trials; 2000 Dec; 21(6 Suppl):379S-389S. PubMed ID: 11189689
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
20. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Weissfeld JL; Fagerstrom RM; O'Brien B;
Control Clin Trials; 2000 Dec; 21(6 Suppl):390S-399S. PubMed ID: 11189690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
